Inebilizumab
Class
Biologic agents
Subclass
Anti-CD19 monoclonal antibodies
Substance name
Inebilizumab, inebilizumab-cdon
Brand names
Uplizna®
Common formulations
Injection
Dosage and administration
Adults patients
Treatment of neuromyelitis optica spectrum disorder • Anti-AQP-4 antibody-positive
Indications for use
Labeled indications
Adults
Interactions
Drug(s)
Check Interactions
Reset
What did you think about this content?
Sign up for free to access the full drug resource